content_top
34 companies, 1 interpreter! Insight, foresight
and recommendation
and recommendation
Osiris Therapeutics, Inc. (OSIR)
0.00
(0.00%)
content_middle
Osiris Therapeutics (OSIR) researches, develops, manufactures, markets, and distributes regenerative medicine products.
OSIR products include Grafix, a cryopreserved placental membrane for treating hard-to-treat acute and chronic wounds, venous leg ulcers, and burns; BIO4, a bone allograft for use in all surgical applications, including spine, trauma, extremity, cranial, and foot and ankle surgery; and Cartiform, a viable chondral allograft that promotes articular cartilage repair to treat focal chondral defects.
Osiris Therapeutics, Inc. was founded in 1992 and is headquartered in Columbia, Maryland.
Previous Close:
5.80
Open:
5.76
Bid:
N/A
Ask:
N/A
1yr Target Price:
4.00
Day's Range:
5.76 - 5.89
52wk Range:
7.01 - 19.30
Volume:
7613
Average Daily Volume:
24675
Market Capitalization:
655.69M
Trailing Annual Dividend Yield:
0.00
Shares Outstanding:
34.53M
content_right
- November 16, 2015 - 10:34am | Earnings Q3
- November 4, 2015 - 8:33am | Research Notes
- November 2, 2015 - 9:02am | Research Notes
- October 6, 2015 - 10:37am | Research Notes, Regulatory
- September 21, 2015 - 11:39am | BOD & C-Suite Updates
- July 14, 2015 - 7:59pm | Earnings Alert
- April 21, 2015 - 9:07am | BOD & C-Suite Updates
- April 9, 2015 - 9:32am | BOD & C-Suite Updates
- February 11, 2015 - 9:00am | Earnings Alert
- December 23, 2014 - 8:21am | Research Notes
- December 8, 2014 - 10:58am | Financings
- December 3, 2014 - 9:25am | BOD & C-Suite Updates
- November 26, 2014 - 9:24am | BOD & C-Suite Updates
- November 14, 2014 - 1:58pm | Earnings
- November 7, 2014 - 12:32pm | Earnings
- October 17, 2014 - 9:13am | Out and About
- October 16, 2014 - 2:13pm | Earnings Q3
- October 16, 2014 - 10:14am | Research Notes
- October 13, 2014 - 10:15am | Earnings Alert
- October 2, 2014 - 10:35am | BOD & C-Suite Updates